Where to turn when a letter isn't enough

Your drug plan didn't answer by its own deadline

Your Part D plan's own deadline to decide passed with no decision recorded. Under Medicare's rules, that silence is legally treated as a denial — and the plan is required to forward your case to the Independent Review Entity automatically, without you having to ask.

1. Call the plan and ask for the case number it used to forward your appeal to C2C Innovative Solutions, the Part D Independent Review Entity.
2. If the plan says it hasn't forwarded the case, tell them it was required to under 42 CFR § 423.590 once its own deadline passed.
3. File a complaint with 1-800-MEDICARE so there's a federal record of the delay.

The plan or C2C should confirm a case number for the forwarded appeal.

The Independent Review Entity is overdue

C2C Innovative Solutions, the Part D Independent Review Entity, has passed its own deadline to decide your case with no decision recorded.

1. Contact C2C and ask for the status of your case using your case number.
2. If C2C can't explain the delay, file a complaint with 1-800-MEDICARE.

C2C should be able to tell you the status of your case and an expected decision date.

Your case is below the dollar amount required for the next level

Requesting an ALJ hearing requires a minimum dollar amount still in dispute, adjusted every year. Your case's amount doesn't currently meet that threshold, so this specific appeal can't go further on its own.

1. Ask a SHIP counselor for a free second opinion on your options.
2. Ask whether other denied drug requests from the same plan year can be combined (aggregated) to reach the threshold.

Aggregating claims to meet the threshold has its own rules about what counts as related claims — a SHIP counselor can help you work through whether yours qualify.

This is where a human often helps

Your case has reached the Administrative Law Judge level or higher. Hearings at this level are more formal, and many families bring in help at this point.

1. Ask about free or low-cost representation for a Medicare Part D ALJ hearing.

Some organizations provide free representation for Medicare appeals at this level; availability varies by location and case type.

You missed a filing deadline

Medicare's own rules allow a late filing for good cause — a real, documentable reason the deadline was missed.

1. Ask the plan or the IRE for a good-cause extension, and explain the specific reason the deadline was missed.

Good cause is decided case by case — a serious illness, a mailing problem, or similar documented reasons are the kind of facts that support it.

You have both Medicare and Medicaid

Being dually eligible for Medicare and Medicaid opens additional help — including Extra Help, which lowers Part D drug costs, and your state's Medicaid ombudsman.

1. Ask whether you're already receiving Extra Help, and if not, how to apply.
2. Ask your state Medicaid ombudsman about drug-coverage help specific to dual-eligible members.

Extra Help can significantly reduce premiums, deductibles, and copays for Part D drugs.

A quality-of-care problem, not a coverage denial

A complaint about the quality of care or service you received is a grievance, handled differently from a coverage appeal.

1. File a grievance directly with the plan, and/or a complaint with 1-800-MEDICARE.

A grievance gets its own written response from the plan, separate from any coverage appeal.

A complaint about the plan's conduct

A complaint about how the plan treated you — not about whether a drug is covered — is a grievance, not an appeal.

1. File a grievance directly with the plan.

The plan must respond to a grievance in writing within its own required timeframe.

This drug can't be covered by Part D at all

Some drugs are excluded from Medicare Part D coverage by statute (for example, most drugs for weight loss, fertility, or cosmetic use) — no appeal can change that, regardless of medical necessity.

1. Ask the plan directly whether it offers this excluded category as a supplemental (non-Part D) benefit.
2. Ask a manufacturer patient-assistance program whether it covers this specific drug.

A statutory exclusion is not appealable, but manufacturer assistance programs and a plan's own optional supplemental benefits sometimes still help with cost.

You may be owed a temporary transition supply

New enrollees and people affected by a mid-year formulary change are entitled to a temporary transition supply of a drug they were already taking, while a permanent solution (an exception or a prescriber switch) is worked out.

1. Ask the pharmacy or plan directly for a transition fill, citing 42 CFR § 423.120(b)(3).
2. If the pharmacy says no, ask the plan's member services line directly.

A transition fill is normally a one-time, temporary supply — typically enough for the plan's standard 30-day transition period — while a permanent request is filed.

The prescriber's office hasn't sent the supporting statement

Most Part D exceptions can't move forward until the prescriber sends a supporting statement — the plan's own clock for deciding an exception doesn't even start until that arrives.

1. Call the prescriber's office directly and ask specifically for the "Part D exception supporting statement" for this drug — front-desk staff may not recognize a more general request.
2. Offer to fax or email the plan's own exception request form to the office to make it a one-step task for them.

A supporting statement can often be provided the same day if the office understands exactly what's being asked for.

You need the medication before an appeal can be decided

If a delay could seriously affect your health, some options exist outside the standard appeal timeline.

1. Ask the pharmacist directly about an emergency supply — many state pharmacy boards allow a short emergency fill at the pharmacist's discretion, separate from the Part D appeal process.
2. Ask the plan for an expedited (24-hour) coverage determination if the standard timeframe could seriously jeopardize your health.

An emergency pharmacy fill (where available) is typically very short-term — it buys time for the coverage determination or exception request to be decided, not a substitute for it.